Diabetic Macular Edema (DME) Completed Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Diabetic Macular Edema / Macular Edema, Diabetic / Diabetic Macular Oedema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01627249Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaTreatment
NCT01661946Bloodstream Absorption of Avastin and Lucentis After Injection Into the EyeOther
NCT01823081Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular EdemaTreatment
NCT00545870Bevacizumab Versus Ranibizumab for Diabetic RetinopathyTreatment
NCT00997191Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)Treatment
NCT02308644Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity StudyTreatment